Tierarztl Prax Ausg K Kleintiere Heimtiere 2010; 38(02): 113-118
DOI: 10.1055/s-0038-1622835
Für Studium und Praxis
Schattauer GmbH

Kognitives Dysfunktionssyndrom beim Hund

Vorkommen, Diagnose und therapeutische MaßnahmenCanine cognitive dysfunction syndromeprevalence, diagnosis and therapeutic measures
B. M. Schneider
1   Lehrstuhl für Tierschutz, Verhaltenskunde, Tierhygiene und Tierhaltung (Vorstand: Prof. Dr. M. H. Erhard), Veterinärwissenschaftliches Department der Ludwig-Maximilians-Universität München
M. H. Erhard
1   Lehrstuhl für Tierschutz, Verhaltenskunde, Tierhygiene und Tierhaltung (Vorstand: Prof. Dr. M. H. Erhard), Veterinärwissenschaftliches Department der Ludwig-Maximilians-Universität München
› Author Affiliations
Further Information

Publication History

Eingegangen: 08 July 2009

Akzeptiert: 23 November 2009

Publication Date:
05 January 2018 (online)


  • Literatur

  • 1 Adams B, Chan A, Callahan H, Milgram NW. The canine as a model of human cognitive aging: recent developments. Prog Neuro-Psychopharm Biol Psychiat 2000; 24: 675-692.
  • 2 Araujo JA, Landsberg GM, Milgram NW, Miolo A. Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, ginkgo biloba, vitamin E, and pyridoxine. Can Vet J 2008; 49: 379-385.
  • 3 Azkona G, Garcia-Belenguer S, Chacón G, Rosado b, León M, Palacio J. Prevalence and risk factors of behavioural changes associated with age-related cognitive impairment in geriatric dogs. J Small Anim Pract 2009; 50: 87-91.
  • 4 Bain MJ, Hart BL, Cliff KD, Ruehl WW. Predicting behavioral changes asso -ciated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001; 218: 1792-1795.
  • 5 Borràs D, Ferrer I, Pumarola M. Age-related changes in the brain of the dog. Vet Pathol 1999; 36: 202-211.
  • 6 Campbell S, Trettien A, Kozan B. A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting. Vet Therapeut 2001; 2: 24-39.
  • 7 Carillo M-C. Ivy GO, Milgram NW, Head E, Wu P, Kitani K. Deprenyl increases activity of superoxide dismutase (SOD) in striatum of dog brain. Life Sci 1994; 54: 1483-1489.
  • 8 Chan AD, Nippak PM, Murphey H, Ikeda-Douglas CJ. Muggenburg B, Head E, Cotman CJ, Milgram NW. Visuospatial impairments in aged canines (canis familiaris): the role of cognitive behavioral therapy. Behav Neurosci 2002; 116: 443-454.
  • 9 Cummings BJ, Head E, Afagh AJ, Milgram NW, Cotman CW. β-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem 1996; 66: 11-23.
  • 10 Dodman NH, Seeler DC, Court MH. Aging changes in the geriatric dog and their impact on anesthesia. Comp Cont Educ Pract 1984; 6: 1106-1113.
  • 11 Hagen TM, Liu J, Lykkesfeldt J. Feeding acetyl-L-carnitine and alpha lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci 2002; 99: 1870-1875.
  • 12 Heath SE, Barabas S, Craze PG. Nutritional supplementation in cases of canine cognitive dysfunction – a clinical trial. Appl Anim Behav Sci 2007; 105: 284-296.
  • 13 Landsberg GM, Ruehl WW. Geriatric behavioral problems. Vet Clin North Am Small Anim Pract 1997; 27: 1537-1559.
  • 14 Landsberg G, Araujo JA. Behavior problems in geriatric pets. Vet Clin North Am Small Anim Pract 2005; 35: 675-698.
  • 15 Landsberg G, Hunthausen W, Ackerman L. eds. Handbook of behaviour problems of the dog and cat Oxford: Elsevier Saunders; 2003
  • 16 Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW, Ames BN. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-α-lipoic acid. Proc Natl Acad Sci USA 2002; 99: 2356-2361.
  • 17 Lookwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of co-enzyme Q10. Biochem Biophys Res Commun 1994; 119: 1504-1508.
  • 18 Milgram NW, Ivy GO, Head E, Murphy MP, Wu PH, Ruehl WW, Yu PH, Durden DA, Davis BA, Paterson IA, Boulton AA. The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog. Neurochem Res 1993; 18: 1211-1219.
  • 19 Milgram NW, Ivy GO, Murphy MP, Head EWUPH, Ruehl WW, Yu PH, Durden DA, Davis BA, Boulton AA. Effects of chronic oral administration of L-deprenyl in the dog. Pharmacol Biochem Behav 1995; 51: 421-428.
  • 20 Milgram NW, Zicker SC, Head E, Muggenburg BA, Murphey H, Ikeda-Douglas CJ, Cotman CW. Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol Aging 2002; 23: 737-745.
  • 21 Milgram NW, Head E, Muggenburg B, Holowachuk D, Murphey H, Estrada J, Ikeda-Douglas CJ, Zicker SC, Cotman CW. Landmark discrimination learning in the dog: effects of age, an antioxidant fortified food, and cognitive strategy. Neurosci Biobehav Rev 2002; 26: 679-695.
  • 22 Milgram NW, Head E, Zicker SC, Ikeda-Douglas C, Murphey H, Muggenburg BA, Siwak CT, Tapp PD, Lowry SR, Cotman CW. Long-term treatment with antioxidants and a program of behavioral enrichment reduces age-dependent impairment in discrimination and reversal learning in beagle dogs. Exp Gerontol 2004; 39: 753-765.
  • 23 Milgram NW, Head E, Zicker SC, Ikeda-Douglas CJ, Murphey H, Muggenburg B, Siwak C, Tapp D, Cotman CW. Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification: a two-year longitudinal study. Neurobiol Aging 2005; 26: 77-90.
  • 24 Milgram NW, Araujo JA, Hagen TM, Treadwell BV, Ames BN. Acetyl-L-carnitine and alpha-lipoic acid supplementation of aged beagle dogs improves learning in two landmark discrimination tests. FASEB J 2007; 21: 3756-3762.
  • 25 Neilson JC, Hart BL, Cliff KD, Ruehl WW. Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001; 18: 1787-1791.
  • 26 Osella MC, Re G, Odore R, Girardi C, Badino P, Barbero R, Bergamasco L. Canine cognitive dysfunction syndrome: prevalence, clinical signs and treatment with a neuroprotective nutraceutical. Appl Anim Behav Sci 2007; 105: 297-310.
  • 27 Peskind ER, Potkin SG, Pomara N, Ott BR, Graham SM, Olin JT, McDonald S. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am J Geriat Psychiat 2006; 14: 704-715.
  • 28 Pugliese M, Geloso MC, Carrasco JL, Mascort J, Michetti F, Mahy N. Canine cognitive deficit correlates with diffuse plaque maturation and S100β(-)astrocytosis but not with insulin cerebrospinal fluid level. Acta Neuropathol 2006; 111: 519-528.
  • 29 Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer’s disease. New Engl J Med 2003; 348: 1333-1341.
  • 30 Rème CA, Dramard V, Kern L, Hofmans J, Halsberghe C, Mombiela DV. Effect of S-adenosylmethionine tablets on the reduction of age-related mental decline in dogs: a double-blinded, placebo-controlled trial. Vet Ther 2008; 9: 69-82.
  • 31 Schneider BM, Dodman N H, Maranda L. Use of memantine in treatment of canine compulsive disorders. J Vet Behav 2009; 4: 118-126.
  • 32 Takeuchi T, Harada E. Age-related changes in sleep-wake rhythm in dog. Behav Brain Res 2002; 136: 193-199.